Redoubling efforts
Story sees the COVID-19 outbreak as an opportunity to identify – and treat – more TB cases, which would have otherwise gone undiagnosed. “It's ironic, but it's been quite good for TB detection in our population group, as we’ve been actively looking for people with respiratory symptoms who are in need of diagnostic investigations,” he says. Tuberculosis is still highly present in London and the team has been finding a lot more cases recently through the current set-up. “TB is there. It never went away.”
“The reality is TB has been killing us since the dawn of time, in millions, and it begs the question: is it technologically insurmountable, or is there a bit of a lack of will and investment?” says Story. “When you think about the progress we've made scientifically, and therapeutically, and socially in terms of thinking about how we're going to actually live with COVID-19, it is a testimony to human achievement, but it shines a really bright light on what we’ve failed to do with TB.”
For him, containing airborne diseases within marginalized populations is the medium, eradicating homelessness is the ultimate goal. “We need a different approach. It comes down to outreach. It comes down to taking the model to people.” Almost half of the team lived the experience of being homeless and they now work for Find&Treat. “So they’ve lived and breathed TB,” says Story. “They're an amazing resource to actually understand how to engage with people, how to get them on site, and more importantly, how to see them not just as a kind of passive recipient of a service, but as an active participant in a service and a resource, a resource to controlling TB and COVID in their own right.”
Although COVID-19 and TB are here to stay for the foreseeable future, Dr. Story’s mobile health unit service continue fighting the good fight – and are seeing positive results. “It is in all our interests to get rid of TB because we share the same air. It is now completely within our grasp to redouble our efforts to find social and technological solutions to TB. We can do it with COVID. We can do it for TB.”